Literature DB >> 3083710

Lowered glutathione-peroxidase activity in asthmatic patients with food and aspirin intolerance.

R Malmgren, G Unge, O Zetterström, H Theorell, K de Wahl.   

Abstract

In analogy with findings from animal experiments, people with low glutathione-peroxidase (GSH-Px) activity could be expected to have altered sensitivities to effects of drugs, chemicals and possibly food. We have investigated GSH-Px activity in 12 patients with intrinsic asthma and food and aspirin intolerance. Ten of the 12 patients had very low or low GSH-Px activity and the frequency of low GSH-Px activity in this group was statistically significant (P less than 0.001) compared with the control material of age- and sex-matched healthy individuals. Our finding of lowered GSH-Px activity in patients with aspirin intolerance may indicate the involvement of hitherto unknown mechanisms in the pathogenesis of asthmatic disorders.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3083710     DOI: 10.1111/j.1398-9995.1986.tb00273.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  4 in total

1.  Reduced selenium in asthmatic subjects in New Zealand.

Authors:  A Flatt; N Pearce; C D Thomson; M R Sears; M F Robinson; R Beasley
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

2.  In vitro release of arachidonic acid metabolites, glutathione peroxidase, and oxygen-free radicals from platelets of asthmatic patients with and without aspirin intolerance.

Authors:  V Plaza; J Prat; J Rosellò; E Ballester; I Ramis; J Mullol; E Gelpí; J L Vives-Corrons; C Picado
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

3.  Selenium status is decreased in patients with intrinsic asthma.

Authors:  J Kadrabová; A Mad'aric; Z Kovaciková; F Podivínsky; E Ginter; F Gazdík
Journal:  Biol Trace Elem Res       Date:  1996-06       Impact factor: 3.738

4.  Release of sulfidoleukotrienes in vitro: its relevance in the diagnosis of pseudoallergy to acetylsalicylic acid.

Authors:  W Czech; E Schöpf; A Kapp
Journal:  Inflamm Res       Date:  1995-07       Impact factor: 4.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.